Hollings Horizons

To read the digital version of Hollings Horizons magazine, click on the magazine cover below or visit our Hollings Horizons flipbook webpage.

a doctor casually leans on a hospital bed in upright position to chat with the patient sitting in it

CAR-T Clinical Trial

CAR-T-cell therapy can be a powerful treatment for blood cancers, but it also has significant side effects. A clinical trial at Hollings seeks to change that.

a family wedding photo featuring the father of the groom, the groom in a cream suit with brown tie, the mother of the groom in taupe holding flowers and the sister of the groom in bronze holding flowers

Hollings Cancer Network

Facing a challenging journey with uterine cancer, Debra Morin made a list of five things to remember each day.

A woman sits on a wooden bench on a pier with marsh and river behind her

Bladder Cancer

After a bladder cancer diagnosis, one patient wants to raise awareness among women about this disease that can be mistaken for a UTI.

Video Spotlight

For patients with non-metastatic liver cancer, pancreatic cancer, or stomach cancer, MUSC Hollings Cancer Center's Next-Day Access program offers appointments with a surgeon on the next business day in most instances. Our mission is to begin treatment as soon as possible. Walk through an appointment with the Next-Day Access team in this video.

Subscribe to Hollings Horizons

Director's Message — Winter 2025

Dr. Raymond DuBois standing by a rail wearing his white doctor's coat

“Outstanding.”

That was the score that MUSC Hollings Cancer Center received at our National Cancer Institute-designation review in April 2024, the highest that the center has scored since first earning NCI designation in 2009. The Outstanding rating underscores our deep commitment to research and the tremendous progress we’ve made in cancer diagnosis, development, progression, treatment and treatment resistance over the last 15 years.

We’ve recently been focusing on translational research and have assembled a top-notch team of scientists who are motivated to see their work in the lab improve patient outcomes in our clinics. For example, we are having incredible success with our CAR-T clinical trial, an immunotherapy approach that channels the body’s own immune system to fight off cancer.

To make a greater impact on the health of our state, we are expanding clinical programs and services throughout South Carolina, such as our Next-Day Access program for abdominal cancers and our new bone marrow transplant clinic.

And, we are helping cancer survivors by providing them with resources like physical therapy, financial counseling, and psychological support services.

The highlights showcased in these pages represent the range of inventive, creative work happening here at Hollings. Our researchers and clinicians are continually seeking ways to understand cancer, improve treatments and, ultimately, to prevent it. We have come a long way in the last 15 years, but we still have a long way to go. We are excited about tackling the challenges that lie ahead.

Best Wishes,

Raymond N. DuBois, M.D., Ph.D.
Director, MUSC Hollings Cancer Center
Associate Provost of Cancer Programs, MUSC

image of the Hollings Cancer Center building with its preserved 1913 facade of columns and brick

Outstanding Performance

The National Cancer Institute renewed MUSC Hollings Cancer Center's NCI designation, awarding the center its best score ever of “outstanding performance.”

two young women sit side by side at a table in a large meeting room. One looks at the other with a smile as the other talks and gestures with her hands

Student Navigators

Hollings is a pilot site for an American Cancer Society program to train college students to navigate patients to needed resources.

a man and woman pose in front of a wall bookshelf

Medication to Quit E-Cigs

A new study is the first in the U.S. to show that an available generic drug could help people stop using e-cigarettes.